This aggregator organizes the screens below it. It does not collect evaluation data and does not have a blended inclusion or exclusion list. Open an evaluated screen to review the exact decision boundary.
Screens in this group
Medical Cannabis and Cannabinoid Products
Identifies companies and other entities that cultivate, manufacture, process, distribute, dispense, or commercialize cannabis or cannabinoid products specifically authorized, prescribed, supplied, or clinically developed for medical or pharmaceutical use. This includes regulated medical cannabis and approved or investigational cannabinoid medicines. Recreational products, industrial hemp and general-wellness CBD without medical positioning, synthetic non-cannabis compounds without cannabinoid activity, ancillary services, and non-commercial research are excluded.
7 included · 6 excluded
Recreational Cannabis and Cannabinoid Products
Identifies companies and other entities that cultivate, manufacture, process, distribute, or directly sell cannabis, psychoactive cannabinoid products, or adult-use cannabis consumer products for non-medical use. Jurisdictional legality is recorded separately and does not change the factual activity. Medical-only products, industrial hemp without adult-use positioning, non-intoxicating wellness CBD without recreational positioning, pharmaceutical cannabinoid medicines, ancillary services, and research or advocacy are excluded.
7 included · 6 excluded
Evidence and evaluation methodology
How sources, entity pathways, decisions, qualifiers, and review history are handled.
Map screens to a client policy
How to choose provider screens, document coverage, and decide what happens after an outcome.